Pfizer Inc. , of New York, said a new smoking-cessation clinical study assessing the efficacy and safety of Chantix/Champix (varenicline) met its primary and secondary endpoints.
(BioWorld-Today-2014-01-22) ...

Ipsen SA , of Paris, said the results of the ELECT Phase III trial testing Somatuline Autogel/Somatuline Depot (lanreotide) showed a statistically significant reduction vs. placebo in the number of days in which immediate-release octreotide was used ...

• Lurasidone, an atypical antipsychotic developed by Dainippon Sumitomo Pharma Co. Ltd. , of Osaka, Japan, and marketed by its subsidiary Sunovion Pharmaceuticals Inc., of Marlborough, Mass., was the subject of five poster presentations at ...